Sign In
Buy XCUR
$2.73
-0.0100 (-0.365%)
At Close: Jun 23, 2026
Ipsen and Exicure Enter Into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders
01:00am, Monday, 02'nd Aug 2021
PARIS & CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News: Disclaimer: Intended for international media and investor audiences only Ipsen (Euronext: IPN; ADR: IPSEY) and Exicure Inc. (NASDA
Exicure Announces Appointment of Brian C. Bock as Chief Financial Officer (CFO)
05:24pm, Thursday, 13'th May 2021
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure Announces Appointment of Brian C. Bock as Chief Financial Officer
Exicure, Inc. (XCUR) Reports Q4 Loss, Misses Revenue Estimates
10:37am, Thursday, 11'th Mar 2021
Exicure, Inc. (XCUR) delivered earnings and revenue surprises of -50.00% and -95.33%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Spherical Nucleic Acid Technology Shows Promising Results in Phase 0 Trial in Patients With Glioblastoma at Northwestern University
10:03am, Thursday, 11'th Mar 2021
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Spherical Nucleic Acid technology shows promising results in phase 0 trial in patients with glioblastoma at Northwestern University.
Exicure, Inc. Reports Full Year 2020 Financial Results and Corporate Progress
08:45am, Thursday, 11'th Mar 2021
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure reported fourth quarter and full year financial results for the year ended December 31, 2020 and provided an update on corporate progress.
Exicure Announces Appointments of Elizabeth Garofalo, M.D., and Andrew Sassine to Its Board of Directors
08:45am, Tuesday, 09'th Mar 2021
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure today announced the appointment of Elizabeth (Betsy) Garofalo, M.D. and Mr. Andrew Sassine to its Board of Directors.
Exicure, Inc. (XCUR) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
01:38pm, Tuesday, 02'nd Mar 2021
Exicure, Inc. (XCUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Exicure Announces Presentation at 2021 H.C. Wainwright Global Life Sciences Conference
07:00am, Tuesday, 23'rd Feb 2021
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure announced that CEO David Giljohann will present at the 2021 H.C. Wainwright Global Life Sciences Conference, March 9-10, 2021.
Exicure Announces Webcast of Presentation at 2021 HC Wainwright BIOCONNECT Conference
07:00am, Tuesday, 29'th Dec 2020
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure announced that David Giljohann, CEO, will present at the HC Wainwright Virtual BIOCONNECT Conference, January 11-14, 2021.
